Anda belum login :: 27 Nov 2024 08:10 WIB
Home
|
Logon
Hidden
»
Administration
»
Collection Detail
Detail
Impact of extranodal extension on prognosis in lymph node-positive gastric cancer
Oleh:
I,-S. Lee
;
Y,-S. Park
;
M,-H. Ryu
;
Song, M. J.
;
Yook, J.-H.
Jenis:
Article from Article - diterbitkan di jurnal ilmiah internasional
Dalam koleksi:
BJS: British Journal of Surgery vol. 101 no. 12 (Nov. 2014)
,
page 1576-1584.
Ketersediaan
Perpustakaan FK
Nomor Panggil:
B15.K
Non-tandon:
1 (dapat dipinjam: 0)
Tandon:
tidak ada
Lihat Detail Induk
Isi artikel
Background The TNM classification system is used widely for tumour staging, and directs the treatment and prognosis of patients with cancer. The aim of this study was to assess the prognostic value of extranodal extension (ENE) in patients with early gastric cancer. Methods All patients who underwent gastrectomy with lymphadenectomy for primary gastric cancer with lymph node metastases between January 2003 and June 2006 were reviewed. Histological slides of metastatic nodes were reviewed by two gastrointestinal pathologists. The association of ENE with clinicopathological characteristics was assessed. The disease-specific survival rate was calculated by the Kaplan–Meier method, and a multivariable Cox regression model was used to identify independent prognostic factors. Results Some 1143 patients were included. ENE was associated with advanced pT and pN category, larger tumour size and lymphovascular/perineural invasion. In multivariable analysis, pT category, pN category, ENE, lymphovascular invasion and perineural invasion were found to be independent prognostic factors in node-positive gastric carcinoma. The 5-year survival rate of patients with ENE was 48·1 per cent, compared with 78·2 per cent for patients without ENE (P?0·001). In the subgroup of patients with early gastric cancer, ENE was associated with a worse 5-year survival rate in patients with early (T1) gastric cancer: 75 per cent in patients with ENE versus 96·9 per cent in those without (P?0·001). Conclusion ENE is an independent prognostic factor in patients with early and advanced gastric cancer.
Opini Anda
Klik untuk menuliskan opini Anda tentang koleksi ini!
Kembali
Process time: 0.015625 second(s)